Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-03-04
1991-04-02
Dentz, Bernard I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514352, 546299, 546310, A61K 3144, C07D21379
Patent
active
050047485
ABSTRACT:
The invention relates to substituted pyridine-2,4-dicarboxylic acid derivatives of the formula I ##STR1## in which R.sup.1 and R.sup.2 have the meanings given. The invention also relates to a process for the preparation of the abovementioned compounds and to their use as medicaments, in particular as fibrosuppressants and immunosuppressants.
REFERENCES:
patent: 4717727 (1988-01-01), Gunzler et al.
"Inhibition of Prolyl-4-Hydroxylase by Structure Analogues of 2-Oxoglutarate"; Gunzler et al., Collagen and Rel. Research, 3, 71.
"The 2-Oxoglutarate Binding Site of Prolyl 4-Hydroxylase"; Majamaa et al.; Eur. J. Biochem. 138, 239-245 (1984).
Beilsteins Handbuch der Organischen Chemie, 4, Auflage, Drittes und Viertes Erganzungswerk, vol. 20, 1979, pp. 1655 and 1778.
Baader Ekkehard
Bickel Martin
Brocks Dietrich
Gunzler Volkmar
Hanauske-Abel Hartmut
Dentz Bernard I.
Hoechst Aktiengesellschaft
LandOfFree
Substituted pyridine-2,4-dicarboxylic acid derivatives and medic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyridine-2,4-dicarboxylic acid derivatives and medic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyridine-2,4-dicarboxylic acid derivatives and medic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-327030